摘要
Large/giant congenital melanocytic nevi (LGCMNs) are extensive congenital melanocytic lesions that are generally attributed to postzygotic somatic mutations, most commonly involving NRAS or BRAF. However, the upstream mechanisms that predispose embryonic melanocyte precursors to acquire these mutations remain poorly understood. Familial clustering of congenital melanocytic nevi (CMNs), including rare families in which more than one member develops LGCMN, raises the possibility of an inherited susceptibility. This study aimed to characterize the germline mutation profiles of familial and sporadic LGCMNs, identify potential predisposing genes and DNA-repair pathways, and estimate the occurrence of LGCMN among genetically predisposed families.
Seventy-eight patients with LGCMN treated at Shanghai Ninth People’s Hospital were systematically screened for a family history of CMN and LGCMN. Three unrelated LGCMN pedigrees with familial LGCMN occurrence were identified. Whole-exome sequencing (WES) was performed on peripheral blood from the three probands and their parents to identify pedigree-level germline variants. Additional WES was performed in 21 unrelated LGCMN patients, including 9 with a family history of CMN and 12 without a CMN family history. Rare germline variants in 276 reported DNA-repair genes were screened using a minor allele frequency threshold of <0.5% in East Asian population databases. Variant deleteriousness was assessed using multiple prediction algorithms, and clinical significance was evaluated according to ACMG and ClinVar classifications. Variants of uncertain significance, likely pathogenic variants, and pathogenic variants were retained for further analysis. The distribution of mutated DNA-repair pathways and recurrently mutated genes was evaluated. Pedigree data were additionally used to estimate LGCMN occurrence among family members considered capable of inheriting a genetic predisposition and across the three LGCMN families.
Among the 78 patients, 18 (23.07%) had a family history of CMN and 3 (3.85%) had a family history of LGCMN. In all three LGCMN pedigrees, rare and predicted deleterious germline variants in DNA-repair genes were identified. Family 1 carried ATM and MLH3 variants, family 2 carried BRCA1 and FANCI variants, and family 3 carried a FANCA variant. In each pedigree, the variants were shared by the proband and the mother from the side of the family in which familial LGCMN occurred. These pedigree-associated variants were classified as variants of uncertain significance according to ACMG/ClinVar criteria but involved genes with established functions in homologous recombination repair (HRR) or mismatch repair (MMR).
In the additional LGCMN cohort, rare and deleterious germline DNA-repair gene variants were detected in all 9 patients with a CMN family history (100%), compared with 7 of 12 patients without a family history (58%). Across the analyzed patients, BRCA1 and ATM were the most frequently mutated DNA-repair genes, with mutation frequencies of 25% and 21%, respectively. Multiple additional HRR genes, including FANCA, FANCI, PALB2, BRCA2, FANCL, FANCG, FANCM, and POLN, were also affected. Variants involving MMR genes, including MSH3, MLH3, and MSH6, and nucleotide-excision repair genes, including ERCC3, ERCC4, and ERCC8, were also observed. Collectively, these findings indicate that germline DNA-repair dysfunction, particularly involving HRR and MMR, may constitute an important susceptibility background for LGCMN.
Pedigree-based estimation showed that 6 of 45 family members considered at risk of inheriting the susceptibility background developed LGCMN, corresponding to an estimated occurrence of 13.3%. Across the three LGCMN families, 6 of 112 family members developed LGCMN, corresponding to an estimated familial occurrence of 5.4%.
This study provides the first systematic germline analysis of LGCMN pedigrees and demonstrates a marked enrichment of rare, potentially deleterious germline variants in DNA-repair genes among patients with familial CMN/LGCMN. The findings support a model in which impaired germline DNA-repair capacity, particularly within HRR and MMR pathways, acts as a genetic susceptibility factor rather than a deterministic Mendelian cause, potentially facilitating the acquisition of pathogenic somatic mutations during embryonic development. BRCA1 and ATM emerged as the most recurrent candidate susceptibility genes. These results expand the understanding of LGCMN pathogenesis from isolated postzygotic events to a potential interaction between inherited genomic vulnerability and somatic oncogenic mutations, and provide clinically relevant information for pedigree assessment, genetic counseling, risk communication, and future mechanistic studies in this rare congenital disorder.
